EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Using a Large Language Model (ChatGPT‐4o) to Assess the Risk of Bias in Randomized Controlled Trials of Medical Interventions: Interrater Agreement With Human Reviewers

Christopher James Rose iD, Julia Bidonde, Martin Ringsten iD, Julie Glanville, Thomas Potrebny, Chris Cooper iD, Ashley Elizabeth Muller, Hans Bugge Bergsund, Jose F Meneses-Echavez, Rigmor C Berg

Cochrane Evidence Synthesis and Methods · 2025-09 · 3 (5)

DOI: 10.1002/cesm.70048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cochrane Evidence Synthesis and Methods, online erschienen am 10.09.2025. Verfasst von Christopher James Rose und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Epidemic Interventions Research Norwegian Institute of Public Health Oslo Norway. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Risk of bias (RoB) assessment is a highly skilled task that is time‐consuming and subject to human error. RoB automation tools have previously used machine learning models built using relatively small task‐specific training sets. Large language models (LLMs; e.g., ChatGPT) are complex models built using non‐task‐specific Internet‐scale training sets. They demonstrate human‐like abilities and might be able to support tasks like RoB assessment.

Methods

Following a published peer‐reviewed protocol, we randomly sampled 100 Cochrane reviews. New or updated reviews that evaluated medical interventions, included ≥ 1 eligible trial, and presented human consensus assessments using Cochrane RoB1 or RoB2 were eligible. We excluded reviews performed under emergency conditions (e.g., COVID‐19), and those on public health or welfare. We randomly sampled one trial from each review. Trials using individual‐ or cluster‐randomized designs were eligible. We extracted human consensus RoB assessments of the trials from the reviews, and methods texts from the trials. We used 25 review‐trial pairs to develop a ChatGPT prompt to assess RoB using trial methods text. We used the prompt and the remaining 75 review‐trial pairs to estimate human‐ChatGPT agreement for “Overall RoB” (primary outcome) and “RoB due to the randomization process”, and ChatGPT‐ChatGPT (intrarater) agreement for “Overall RoB”. We used ChatGPT‐4o (February 2025) throughout.

Results

The 75 reviews were sampled from 35 Cochrane review groups, and all used RoB1. The 75 trials spanned five decades, and all but one were published in English. Human‐ChatGPT agreement for “Overall RoB” assessment was 50.7% (95% CI 39.3%–62.0%), substantially higher than expected by chance ( p = 0.0015). Human‐ChatGPT agreement for “RoB due to the randomization process” was 78.7% (95% CI 69.4%–88.0%; p < 0.001). ChatGPT‐ChatGPT agreement was 74.7% (95% CI 64.8%–84.6%; p < 0.001).

Conclusions

ChatGPT appears to have some ability to assess RoB and is unlikely to be guessing or “hallucinating”. The estimated agreement for “Overall RoB” is well above estimates of agreement reported for some human reviewers, but below the highest estimates. LLM‐based systems for assessing RoB may be able to help streamline and improve evidence synthesis production.

Schlagwörter

Stichwörter der Autor:innen

ChatGPTLLMRoBartificial intelligenceevidence synthesislarge language modelrisk of bias

Autor:innen und Institutionen

  • Center for Epidemic Interventions Research Norwegian Institute of Public Health Oslo Norway.
  • Division of Health Services Norwegian Institute of Public Health Oslo Norway.
  • School of Rehabilitation Science University of Saskatchewan Saskatoon Saskatchewan Canada.
  • Cochrane Sweden Skåne University Hospital, Lund University Lund Sweden.
  • Glanville.info York UK.
  • Section Evidence-Based Practice Western Norway University of Applied Sciences Bergen Norway.

ORCID-Profile: Christopher James Rose, Martin Ringsten, Chris Cooper

Zitieren

APA

Rose, C. J., Bidonde, J., Ringsten, M., Glanville, J., Potrebny, T., Cooper, C., Muller, A. E., Bergsund, H. B., Meneses-Echavez, J. F., & Berg, R. C. (2025). Using a Large Language Model (ChatGPT‐4o) to Assess the Risk of Bias in Randomized Controlled Trials of Medical Interventions: Interrater Agreement With Human Reviewers. Cochrane Evidence Synthesis and Methods, 3(5). https://doi.org/10.1002/cesm.70048

Vancouver

Rose CJ, Bidonde J, Ringsten M, Glanville J, Potrebny T, Cooper C, et al. Using a Large Language Model (ChatGPT‐4o) to Assess the Risk of Bias in Randomized Controlled Trials of Medical Interventions: Interrater Agreement With Human Reviewers. Cochrane Evidence Synthesis and Methods. 2025;3(5). doi:10.1002/cesm.70048

BibTeX
@article{Rose2025,
  author = {Rose, Christopher James and Bidonde, Julia and Ringsten, Martin and Glanville, Julie and Potrebny, Thomas and Cooper, Chris and Muller, Ashley Elizabeth and Bergsund, Hans Bugge and Meneses-Echavez, Jose F and Berg, Rigmor C},
  title = {Using a Large Language Model (ChatGPT‐4o) to Assess the Risk of Bias in Randomized Controlled Trials of Medical Interventions: Interrater Agreement With Human Reviewers},
  journal = {Cochrane Evidence Synthesis and Methods},
  year = {2025},
  volume = {3},
  number = {5},
  doi = {10.1002/cesm.70048}
}
Kostenlos starten →